Neogepatect

Roman name

Neohepatect

Indications

Emergency prevention of hepatitis B after contact with the infected material (blood, plasma, serum), the prevention of HIV liver transplant from Hbsag-polaugitionah patients, the prevention of hepatitis B in newborns whose mothers are HIV surface antigen hepatitis B, the people are great (to the operation of re gemotransfuziei, haemodialysis, etc.) or constant risk of infection, including unable to develop enough protective antibodies.

Pregnancy and lactation

With caution.

Contraindications

Hypersensitivity, Carrier surface antigen of hepatitis B.

Side-Effects

Headache, fever, increased body temperature, nausea, vomiting, lomota in joints, pain in the back, allergic reactions. Seldom-reduction actions, in a few cases, anaphylactic shock, the symptoms of aseptic meningitis (severe headache, nausea, vomiting, increased body temperature, rigidity cervical muscles SHP, a violation of consciousness), the worsening renal failure in patients with compromised renal function.

Specific guidance

The mixed with other drugs because of the risk denaturation Belka.vozmozhno a lozhnopolaugitionah data serologicescom study.

Patient interaction

Impact on the living virus vaccines (measles, rubella, mumps and chicken pox).

Storage conditions

In the dark place at a temperature of 2-8 ° C (not freezing)

Shelf life

1.5 years

The registration

015018/01-2003

The drug forms

Colorless or white light or slightly opalestiruty solution.

Directory → Immunotropona funds → Immunoglobulins → Neogepatect